Low CPEB1 levels may predict the benefit of 5-fluorouracil treatment in patients with colon or stomach adenocarcinoma

BACKGROUND: For patients with colon or stomach adenocarcinoma, 5-fluorouracil (5-FU) is an essential component of systemic chemotherapy in the palliative and adjuvant settings. The post-transcriptional regulatory factor cytoplasmic polyadenylation element-binding protein 1 (CPEB1) has been reported...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Jing-Zhu, Niu, Dan-Dan, Huang, Zhi-Ping, Hong, Yong-Gang, Wang, Zhen-Guang, Yang, Le, Zhao, Bo-Lun, Qiao, Guang-Lei, Ouyang, Liu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459193/
https://www.ncbi.nlm.nih.gov/pubmed/36092352
http://dx.doi.org/10.21037/jgo-22-561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459193/
https://www.ncbi.nlm.nih.gov/pubmed/36092352
http://dx.doi.org/10.21037/jgo-22-561

Ejemplares similares